Ketoprofene Biogaran

Ketoprofen, the active ingredient in Ketoprofene Biogaran, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It is employed to relieve inflammation and pain in musculoskeletal and rheumatic conditions. GNH USA supplies Ketoprofene Biogaran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketoprofen is an NSAID that reduces inflammation and pain in several musculoskeletal disorders. - Rheumatoid arthritis: decreases joint inflammation and pain, improving mobility. - Osteoarthritis: alleviates chronic joint pain and stiffness associated with cartilage degeneration. - Ankylosing spondylitis: reduces spinal inflammation and discomfort. - Acute musculoskeletal pain: provides rapid relief of pain from sprains, strains or injuries. - Post‑operative pain: helps control moderate pain following surgical procedures.

Ketoprofen may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dyspepsia or stomach upset - Nausea or vomiting - Headache - Dizziness - Mild skin rash - Elevated liver enzymes

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration - Severe renal impairment - Hepatic failure - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Anaphylactic reactions - Cardiovascular thrombotic events

When prescribing or dispensing Ketoprofene Biogaran, consider the following safety measures. - Assess gastrointestinal risk: avoid in patients with a history of ulcers or GI bleeding. - Monitor renal function: use caution in patients with renal insufficiency. - Avoid in known hypersensitivity to ketoprofen or other NSAIDs. - Use caution with anticoagulants: increased bleeding risk. - Use caution in cardiovascular disease: may increase thrombotic risk. - Store at ambient temperature: keep in the original pack, protect from moisture.

Ketoprofen can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Corticosteroids: increased risk of ulceration. - Lithium: elevated lithium serum levels. - Methotrexate: reduced clearance, potential toxicity.

Moderate Interactions (Monitor Closely):\n- Diuretics: possible reduction in renal perfusion. - ACE inhibitors or ARBs: may impair renal function. - Beta‑blockers: potential for reduced antihypertensive effect. - Digoxin: altered plasma concentrations. - Cyclosporine: increased nephrotoxicity risk.